Abstract:Introduction Parkinson’s disease (PD) is common neurodegenerative disease where oxidative stress and mitochondrial dysfunction play important roles in its progression. Tetramethylpyrazine nitrone (TBN), a potent free radical scavenger, has shown protective effects in various neurological conditions. However, the neuroprotective mechanisms of TBN in PD models remain unclear. Objectives We aimed to investigate TBN’s neuroprotective effects and mechanisms in PD models. Methods TBN’s neuroprotection was initially measured in MPP+/MPTP-induced PD models. Subsequently, a luciferase reporter assay was used to detect peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α) promoter activity. Effects of TBN on antioxidant damage and the PGC-1α/Nuclear factor erythroid-2-related factor 2 (Nrf2) pathway were thoroughly investigated. Results In MPP+-induced cell model, TBN (30–300 μM) increased cell survival by 9.95 % (P < 0.05), 16.63 % (P < 0.001), and 24.09 % (P < 0.001), respectively. TBN enhanced oxidative phosphorylation (P < 0.05) and restored PGC-1α transcriptional activity suppressed by MPP+ (84.30 % vs 59.03 %, P < 0.01). In MPTP-treated mice, TBN (30 mg/kg) ameliorated motor impairment, increased striatal dopamine levels (16.75 %, P < 0.001), dopaminergic neurons survival (27.12 %, P < 0.001), and tyrosine hydroxylase expression (28.07 %, P < 0.01). Selegiline, a positive control, increased dopamine levels (15.35 %, P < 0.001) and dopaminergic neurons survival (25.34 %, P < 0.001). Additionally, TBN reduced oxidative products and activated the PGC-1α/Nrf2 pathway. PGC-1α knockdown diminished TBN’s neuroprotective effects, decreasing cell viability from 73.65 % to 56.87 % (P < 0.001). Conclusion TBN has demonstrated consistent effectiveness in MPP+-induced midbrain neurons and MPTP-induced mice. Notably, the therapeutic effect of TBN in mitigating motor deficits and neurodegeneration is superior to selegiline. The neuroprotective mechanisms of TBN are associated with activation of the PGC-1α/Nrf2 pathway, thereby reducing oxidative stress and maintaining mitochondrial function. These findings suggest that TBN may be a promising therapeutic candidate for PD, warranting further development and investigation.

No Synergism Between Bis(Propyl)-Cognitin and Rasagiline on Protecting Dopaminergic Neurons in Parkinson'S Disease Mice

Activation of Transcription Factor MEF2D by Bis(3)-cognitin Protects Dopaminergic Neurons and Ameliorates Parkinsonian Motor Defects

Bis(propyl)-cognitin Protects Against Glutamate-Induced Neuro-Excitotoxicity Via Concurrent Regulation of NO, MAPK/ERK and PI3-K/Akt/GSK3β Pathways.

Ginsenoside Rb1 confers neuroprotection via promotion of glutamate transporters in a mouse model of Parkinson's disease.

Ginsenoside Rb1 regulates prefrontal cortical GABAergic transmission in MPTP-treated mice.

Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinson's Disease Mouse Model.

Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway

Significant Combination of Aβ Aggregation Inhibitory and Neuroprotective Properties in Silico, in Vitro and in Vivo by Bis(propyl)-Cognitin, a Multifunctional Anti-Alzheimer’s Agent

Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model

[Protective Effects of Cistanche Total Glycosides on Dopaminergic Neuron in Substantia Nigra of Model Mice of Parkinson's Disease].

Protective effects of Dabuyin Pills, Qianzheng Powder and both on neurons and activity of brain mitochondrial complex enzyme in mice with Parkinson's disease

Substantial Neuroprotective and Neurite Outgrowth-Promoting Activities by Bis(propyl)-cognitin Via the Activation of Alpha7-nAChR, a Promising Anti-Alzheimer’s Dimer

Integrative Therapy Using Coenzyme Q10 and Minocycline in 1-Methyl-4-phenylpyridinium-induced Hemiparkinson Rats

Ginsenoside Rg3 exerts a neuroprotective effect in rotenone-induced Parkinson's disease mice via its anti-oxidative properties

Involvement of Monoamine Oxidase Inhibition in Neuroprotective and Neurorestorative Effects of Ginkgo Biloba Extract Against Mptp-Induced Nigrostriatal Dopaminergic Toxicity in C57 Mice

Synergistic effects of ceftriaxone and erythropoietin on neuronal and behavioral deficits in an MPTP-induced animal model of Parkinson's disease dementia

A bibenzyl compound 20C protects rats against 6-OHDA-induced damage by regulating adaptive immunity associated molecules

N-cystaminylbiguanide MC001 prevents neuron cell death and alleviates motor deficits in the MPTP-model of Parkinson's disease

Ginsenoside Rg1 Attenuates Motor Impairment and Neuroinflammation in the MPTP-probenecid-induced Parkinsonism Mouse Model by Targeting Α-Synuclein Abnormalities in the Substantia Nigra.

Ginsenoside Rb1 promotes glutamate transporters and plays neuroprotective roles in Parkinson's disease model

Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson’s disease models